Inogen (INGN) Stock: Buy, Sell, or Hold?
INGN - Inogen Inc
$6.67
-0.02 (-0.30%)
▼
5d:
+8.81%
30d:
+27.53%
90d:
+5.54%
WAIT
LOW Confidence
Analysis Updated: Oct 21, 2026 12:00 AM ET
Earnings: Nov 05, 2026
13d
Get Alerted When INGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: INGN shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: INGN shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: INGN is currently trading at $6.67, which is considered extended relative to its 30-day fair value range of $5.21 to $6.28. From a valuation perspective, the stock is trading at a discount (Forward PE: -41.7) compared to its historical average (120.2). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, INGN is in a downtrend. The price is approaching resistance at $6.79. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: INGN scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $12.00 (+79.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, INGN is in a downtrend. The price is approaching resistance at $6.79. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: INGN scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $12.00 (+79.9%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$5.21 -
$6.28
Company Quality Score
23/100
(STRONG SELL)
Options IV Signal
30th percentile
(NORMAL)
Volume Confirmation
HIGH
Confidence Score
36.5%
All Signals
- BEARISH: Price extended above range (+6.2% above its trading range)
- NEUTRAL: Options fairly priced (IV 30th percentile)
- BEARISH: Weak technical setup (0/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 79.9% below Wall St target ($12.00)
- BULLISH: Market expects only 0% annual growth - appears undervalued
- WARNING: Composite score 22/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$5.21 -
$6.28
Current vs Trading Range
EXTENDED
Expected Move (7 Days)
±$0.64
(9.6%)
Support & Resistance Levels
Support Level
$5.74
Resistance Level
$6.79
Current Trend
Downtrend
Technical data as of
Oct 21, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-41.69
Wall Street Target
$12.00
(+79.9%)
Revenue Growth (YoY)
3.0%
Earnings Growth (YoY)
87.3%
Profit Margin
-6.9%
PE vs Historical
-41.7 vs 120.2
CHEAP
Share & Embed Analysis
Last updated: October 22, 2026 9:12 AM ET
Data refreshes hourly during market hours. Next update: 10:12 AM
Data refreshes hourly during market hours. Next update: 10:12 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is INGN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
31 analysts |
$59 | 50 HOLD |
|
MDT
Medtronic PLC |
BUY
29 analysts |
$105 | 43 HOLD |
|
AXGN
Axogen Inc |
STRONG BUY
12 analysts |
$54 | 75 BUY |
|
TNDM
Tandem Diabetes Care Inc |
BUY
25 analysts |
$28 | 54 HOLD |
|
IRTC
iRhythm Technologies Inc |
STRONG BUY
15 analysts |
$171 | 49 HOLD |
